How to build a future-proof AI adoption roadmap in pharma marketing

By Manuel Mitola, expert trainer of The AI for Pharma Marketing Course 
 

As the pharma industry races to maximally use the power of AI, many marketing teams are trying to figure out how to best adopt it. For pharma marketers aiming to stay ahead, implementing AI goes beyond choosing the right tools. It demands a strategic, well-structured AI adoption roadmap, supported by robust Organisational Change Management (OCM).  Only then will promising use cases transform into scalable, sustainable business practices.
 

Why OCM is the missing link in AI adoption

Many AI initiatives fail not because the technology isn’t ready, but because the organisation isn’t. OCM focuses on preparing people, processes, and structures for successful and sustainable change.

A solid OCM strategy addresses:

• Leadership engagement – To secure the right sponsorship for AI initiatives
• Stakeholder engagement – Communicating benefits of AI across teams and obtaining early buy-in
• Training & support – Teams need the confidence and trust to work with AI
• Managing resistance to change – The perceived threat of AI and reluctance to change needs to be addressed 
• KPIs & measurement – Demonstrating ROI early and often
• Contingency planning – As with all innovations, possible failures, changes in direction or delays need to be anticipated

In the course, this framework is explored in depth, highlighting why culture is just as important as capability when it comes to adopting AI in pharma marketing.
 

From spark to scale: The AI adoption roadmap

The path to successful AI integration begins with a spark, an idea, a challenge, or a small proof-of-concept. But once the initial excitement fades, only a strong roadmap can keep the momentum alive.

Manuel presents a structured AI Adoption Roadmap with four clear phases:
 

1. Mapping

This foundational phase assesses the current status in the company when it comes to 4 critical areas:

• AI Understanding – Do all involved stakeholders master the core concepts and relevance to AI in pharma?
• Skills – What are the current competencies?
• Tech Readiness – What’s the level of maturity?
• SOPs – Do we have standard operating procedures in place that align with AI integration?
   

2. Benchmark & goals

• Needs – What are your pain points or opportunities?
• Goals – What business outcomes should AI drive?
   

3. Gap analysis

Understand the delta between where you are and where you need to be. And you will have to identify your priorities, focusing on high-impact, feasible initiatives.
 

4. Roadmap definition

This is where planning becomes action:

• Feasibility – Evaluate resource needs, risks, and readiness
• Planning – Develop an execution path. You will typically have 1 of 2 situations:
  • Full-blast initiatives (e.g. sales force upskilling)
  • Selective tool adoption – golden advice: Start small, test, scale
     

Source: AI for Pharma Marketing – Manuel Mitola

Creating an AI-ready culture

Unlike traditional tools, AI systems learn through failure, millions of them! Cultivating an organisational mindset that welcomes experimentation, transparency, and lifelong learning is key.

Privacy concerns, legal and compliance hurdles, and cybersecurity risks can’t be ignored. But through early engagement, transparent communication, and continuous training, these challenges can be transformed into opportunities.
 

Ready to move from pilots to productivity?